New papers on Cancer care
19 new papers on cancer care in the last 7 days, within Medicine & health. These are the 19 Pipette rates most worth reading, with the main result in the authors' own words.
The best of the week
Multigene-engineered fibroblast-derived biomimetic vesicles for cancer multimodal targeting and immune reprogramming
Using this platform, we construct multigene-engineered fibroblast-derived nanovesicles (X-Fb-MNVs) coexpressing critical chemokine receptor CXCR4 and adhesion ligand iRGD, as well as PD-1 and CD47 protein, which achieved robust and broad-spectrum tumor targeting across breast, liver, pancreatic, and colon cancer PDX models.
Peer-reviewed journalBold claims, read criticallyReal-world useCytotoxic drugs and bispecific T cell engagers synergize to rewire host immunity and elicit polyclonal antitumor T cell responses
Here we show that tumor-associated antigen (TAA)-targeted CD28 bispecific antibodies (TAAxCD28) convert cytotoxic agents into drivers of durable antitumor immunity.
Peer-reviewed journalBold claims, read criticallyReal-world useAlbumin-bound paclitaxel–induced stromal reprogramming drives resistance to neoadjuvant chemotherapy in patients with pancreatic cancer
These findings map chemotherapy-induced CAF plasticity, reveal a TMEM100-AREG axis of resistance, and highlight TMEM100 + CAFs as a promising target to sensitize PDAC to neoadjuvant treatment.
Peer-reviewed journalReal-world useThe contribution of Neanderthal ancestry to cancer risk
Twelve cancers have multiple Neanderthal alleles significantly associated with variation in risk.
PreprintIzalontamab Brengitecan in Recurrent or Metastatic Esophageal Squamous Cell Carcinoma: The PANKU-Esophagus01 Randomized Clinical Trial
Conclusions and Relevance Izalontamab brengitecan significantly improved PFS and OS vs chemotherapy in patients with recurrent or metastatic ESCC whose disease had progressed after first-line treatment.
Peer-reviewed journalReal-world usePartially functional hypomorphic missense variants in BRCA2 are reduced penetrance pathogenic variants
Here we show that 70 candidate hypomorphic missense variants in the DNA-binding domain of BRCA2 reduce homologous recombination DNA repair activity and endogenous cell survival, decrease RAD51 foci formation, and increase sensitivity to Poly(ADP-ribose) polymerase inhibitors.
Peer-reviewed journalReal-world useExciton binding regulation in oxygen-independent tumor photooxidation enables synchronous photoluminescence for cancer theranostics
This work establishes exciton management as a universal design principle to synchronize photooxidation and photoluminescence and supports the development of organic semiconductors for cancer theranostics.
Peer-reviewed journalBold claims, read criticallyReal-world useIntegrated Genomic and Transcriptomic Profiling Reveals Distinct Biological Programs and Therapeutic Opportunities in Cancer of Unknown Primary
Together, these findings provide a molecular framework for understanding CUP heterogeneity and support therapeutic stratification by both ToO predictions and tumor-specific molecular alterations.
PreprintReal-world useWhole-genome sequencing enables improved AML diagnostics and refines assessment of TP53 allelic state and complex karyotype
Collectively, these results support paired tumor-normal WGS as a single comprehensive assay well suited for AML diagnostics according to current classification and risk-stratification systems, while refining assessment of TP53 allelic state and karyotypic complexity.
PreprintReal-world useNormalized membrane ratio of TROP2 as a predictor of clinical outcomes with datopotamab deruxtecan in non-small-cell lung cancer
Progression-free survival was longer in Dato-DXd-treated (median 7.2 versus 4.0 months; hazard ratio 0.40, 95% confidence interval 0.25–0.64) but not docetaxel-treated (median 4.1 versus 4.4 months; hazard ratio 0.94, 95% confidence interval 0.59–1.49) patients with TROP2 NMR-positive versus TROP2 NMR-negative samples (treatment by biomarker status interaction P = 0.0098), indicating that TROP2 NMR may be a predictive biomarker for Dato-DXd.
Peer-reviewed journalReal-world useGenome-wide association meta-analysis of atrophic gastritis reveals anti H. pylori IgG serostatus dependent associations and genetic overlap with gastric cancer
They highlight epithelial and mucus barrier-related pathways in seropositive AG/SAG and immune-related pathways in seronegative cases, while also providing evidence of a shared genetic basis between AG and GC.
PreprintCancer risk and survival outcomes in germline POT1 variant carriers
Conclusion: POT1 is a cancer susceptibility gene associated with a moderate (1.5-3.5-fold) increased cancer risk.
PreprintReal-world useOsimertinib, platinum, and etoposide for patients with metastatic EGFR / TP53 / RB1 -mutant lung cancers at risk for histological transformation
Despite the addition of SCLC-directed chemotherapy, nearly half of patients (5 of 11) underwent SCLC transformation, with median progression-free survival of 11 months and overall survival of 33 months.
Peer-reviewed journalReal-world useDecoding cancer therapy resistance through advanced 3D organoid systems
Here, we review the applications of 3D cancer models, including scaffold-free spheroids, patient-derived organoids (PDOs) biobanks, and microphysiological systems (MPSs), in drug resistance modeling and personalized therapy.
Peer-reviewed journalReal-world useHierarchical Graph Learning with Multimodal Distillation for Breast Cancer Survival Prediction
In this paper, we propose HEAL-Surv, a teacher-student framework that uses both modalities during training to predict five-year net disease-specific survival (DSS) from clinical variables and molecular profiles at inference.
PreprintReal-world useCONSORTiUM-IO: A Phase 1 Study Evaluating VE800 Plus Nivolumab in Treatment of Select Refractory or Metastatic Cancers
VE800 plus nivolumab was well tolerated but offered no improvement over historic response rates.
PreprintReal-world usePhase I Clinical Trial of Allogeneic Cytomegalovirus-specific T Cells in Combination with Pembrolizumab for Recurrent Glioblastoma
Conclusions: Allogeneic CMV-specific T-cell therapy combined with pembrolizumab was safe in recurrent GBM, supporting further evaluation of this strategy to overcome immune dysfunction in GBM.
PreprintReal-world useFeasibility and Psychological Outcomes of a Clinical Meditation Intervention for Patients with Cancer: A Mixed-Methods Pilot Study
ConclusionsThis mixed-methods pilot study suggests that Clinical Meditation may be feasible and acceptable for patients with cancer, although sustaining meditation practice remains challenging.
PreprintReal-world usePerioperative Safety, Surgical Morbidity, and Survival Outcomes of Neoadjuvant Chemotherapy (NACT-IDS) versus Primary Debulking Surgery (PDS) in Elderly Patients with Advanced Epithelial Ovarian Cancer: A Systematic Review and Meta-Analysis
Conclusion: For older women with advanced epithelial ovarian cancer, NACT-IDS significantly improves perioperative safety, accelerates hospital recovery, and maximizes complete resection rates compared to upfront PDS.
PreprintBold claims, read criticallyReal-world use